Puma Bio (PBYI) Revenue & Revenue Breakdown
Puma Bio Revenue Highlights
Latest Revenue (Y)
$235.64M
Latest Revenue (Q)
$56.14M
Main Segment (Y)
Royalty
Main Geography (Y)
Royalty
Puma Bio Revenue by Period
Puma Bio Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $235.64M | 3.35% |
2022-12-31 | $228.00M | -9.95% |
2021-12-31 | $253.20M | 12.48% |
2020-12-31 | $225.10M | -17.33% |
2019-12-31 | $272.30M | 8.49% |
2018-12-31 | $251.00M | 806.14% |
2017-12-31 | $27.70M | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2012-12-31 | - | -100.00% |
2011-12-31 | $-281.10K | 100.00% |
2010-12-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2007-12-31 | - | - |
Puma Bio Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $56.14M | 19.23% |
2024-06-30 | $47.08M | 7.58% |
2024-03-31 | $43.77M | -39.36% |
2023-12-31 | $72.18M | 28.62% |
2023-09-30 | $56.12M | 2.84% |
2023-06-30 | $54.57M | 3.40% |
2023-03-31 | $52.77M | -19.67% |
2022-12-31 | $65.70M | 15.06% |
2022-09-30 | $57.10M | -4.06% |
2022-06-30 | $59.52M | 30.13% |
2022-03-31 | $45.74M | -17.44% |
2021-12-31 | $55.40M | 19.80% |
2021-09-30 | $46.24M | -13.37% |
2021-06-30 | $53.38M | -45.62% |
2021-03-31 | $98.17M | 86.63% |
2020-12-31 | $52.60M | 3.64% |
2020-09-30 | $50.75M | -28.09% |
2020-06-30 | $70.58M | 37.81% |
2020-03-31 | $51.22M | -18.57% |
2019-12-31 | $62.90M | 11.52% |
2019-09-30 | $56.40M | 4.60% |
2019-06-30 | $53.92M | -45.59% |
2019-03-31 | $99.10M | 39.38% |
2018-12-31 | $71.10M | 13.58% |
2018-09-30 | $62.60M | 23.31% |
2018-06-30 | $50.77M | -23.68% |
2018-03-31 | $66.52M | 207.94% |
2017-12-31 | $21.60M | 255.44% |
2017-09-30 | $6.08M | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2013-09-30 | - | 100.00% |
2013-06-30 | - | 100.00% |
2013-03-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2012-09-30 | - | 100.00% |
2012-06-30 | - | 100.00% |
2012-03-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2011-09-30 | - | 100.00% |
2011-06-30 | - | 100.00% |
2011-03-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2010-09-30 | - | 100.00% |
2010-06-30 | - | 100.00% |
2010-03-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2009-09-30 | - | 100.00% |
2009-06-30 | - | 100.00% |
2009-03-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2008-09-30 | - | 100.00% |
2008-06-30 | - | 100.00% |
2008-03-31 | - | 100.00% |
2007-12-31 | - | - |
Puma Bio Revenue Breakdown
Puma Bio Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 20 | Dec 19 | Dec 18 |
---|---|---|---|
Royalty | $5.68M | $391.00K | - |
License | $2.50M | $60.25M | $50.50M |
Product | - | $211.62M | $200.49M |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Jun 24 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Royalty | $24.41M | $2.69M | $4.28M | $2.35M | $2.54M | $1.42M | $1.11M | $608.00K | $216.00K | $120.00K | $55.00K | - | - | - | - |
Product | $56.14M | $44.40M | $48.86M | $50.02M | $48.77M | $48.61M | $58.71M | $53.48M | $53.86M | $45.57M | $61.08M | $52.63M | $50.77M | - | - |
License | - | - | $250.00K | $2.50M | $2.70M | $20.70M | $2.00M | $4.00M | $2.75M | - | $53.50M | $10.00M | $10.00M | $30.50M | - |
Latest
Puma Bio Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 20 | Dec 19 | Dec 18 |
---|---|---|---|
Royalty | $5.68M | $391.00K | - |
License | $2.50M | $60.25M | $50.50M |
Product | - | $211.62M | $200.49M |
Latest
Quarterly Revenue by Country
Country | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Royalty | $4.28M | $2.35M | $2.54M | $1.42M | $1.11M | $608.00K | $216.00K | $120.00K | $55.00K | - | - | - | - |
Product | $48.86M | $50.02M | $48.77M | $48.61M | $58.71M | $53.48M | $53.86M | $45.57M | $61.08M | $52.63M | $50.77M | - | - |
License | $250.00K | $2.50M | $2.70M | $20.70M | $2.00M | $4.00M | $2.75M | - | $53.50M | $10.00M | $10.00M | $30.50M | - |
Latest
Puma Bio Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
SRPT | Sarepta Therapeutics | $1.24B | $362.93M |
PTCT | PTC Therapeutics | $937.82M | $135.42M |
RARE | Ultragenyx Pharmaceutical | $434.25M | $147.03M |
CHRS | Coherus BioSciences | $257.24M | $70.77M |
PBYI | Puma Bio | $235.64M | $56.14M |
HRTX | Heron Therapeutics | $127.04M | $36.02M |
TSVT | 2seventy bio | $100.39M | $13.53M |
ARVN | Arvinas | $78.50M | $102.40M |
MGNX | MacroGenics | $58.75M | $110.71M |
RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
CRNX | Crinetics Pharmaceuticals | $4.01M | - |
IOVA | Iovance Biotherapeutics | $1.19M | $58.55M |
VKTX | Viking Therapeutics | - | - |
KURA | Kura Oncology | - | - |
MDGL | Madrigal Pharmaceuticals | - | $62.17M |
LRMR | Larimar Therapeutics | - | - |
HEPA | Hepion Pharmaceuticals | - | - |